Cynosure Group’s Insmed INSM Stock Holding History

Cynosure Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$482K	Buy	2,947 +241	+9%	+$37.1K	0.06%	87
2025 Q4	$471K	Buy	+2,706	New	+$494K	0.05%	228

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cynosure Group's INSM Position: Q1 2026 in Review

Cynosure Group increased its Insmed (INSM) stake by 8.9% in Q1 2026, buying an estimated $37.1K and bringing the position to 2,947 shares worth $482K. The position accounts for 0.06% of the portfolio, ranked #87.

Cynosure Group first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Cynosure Group held 2,947 shares of Insmed worth $482K as of Q1 2026.
Cynosure Group bought 241 Insmed shares in Q1 2026, an estimated $37.1K.
Insmed made up 0.06% of Cynosure Group's portfolio in Q1 2026, its #87 holding.
Cynosure Group first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.